REGENXBIO Inc. (RGNX): Price and Financial Metrics

RGNX POWR Grades

• Value is the dimension where RGNX ranks best; there it ranks ahead of 70.29% of US stocks.
• The strongest trend for RGNX is in Quality, which has been heading up over the past 179 days.
• RGNX ranks lowest in Sentiment; there it ranks in the 8th percentile.

RGNX Stock Summary

• Of note is the ratio of REGENXBIO INC's sales and general administrative expense to its total operating expenses; merely 11.66% of US stocks have a lower such ratio.
• In terms of twelve month growth in earnings before interest and taxes, REGENXBIO INC is reporting a growth rate of -299.62%; that's higher than merely 5.06% of US stocks.
• As for revenue growth, note that RGNX's revenue has grown -79.98% over the past 12 months; that beats the revenue growth of merely 2.15% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to REGENXBIO INC are SELB, TSVT, ENTA, VIR, and STRO.
• Visit RGNX's SEC page to see the company's official filings. To visit the company's web site, go to www.regenxbio.com.

RGNX Valuation Summary

• In comparison to the median Healthcare stock, RGNX's price/earnings ratio is 110.64% lower, now standing at -2.9.
• Over the past 97 months, RGNX's price/sales ratio has gone down 197.7.

Below are key valuation metrics over time for RGNX.

RGNX Growth Metrics

The year over year net cashflow from operations growth rate now stands at 442.33%.
• Its year over year revenue growth rate is now at 204.02%.
• The 5 year revenue growth rate now stands at 1017.89%.

RGNX's revenue has moved up $444,801,000 over the prior 33 months.

The table below shows RGNX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	480.034	158.121	73.637
2022-06-30	484.295	172.218	90.716
2022-03-31	473.681	204.095	101.256
2021-12-31	470.347	218.875	127.84
2021-09-30	93.137	-67.894	-212.424
2021-06-30	161.276	-67.995	-145.228

RGNX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RGNX has a Quality Grade of D, ranking ahead of 18.52% of graded US stocks.
• RGNX's asset turnover comes in at 0.116 -- ranking 250th of 682 Pharmaceutical Products stocks.
• PTGX, ARDX, and CBAY are the stocks whose asset turnover ratios are most correlated with RGNX.

The table below shows RGNX's key quality metrics over time.